Oragenics (OGEN) Tax Provisions (2010 - 2026)
Oragenics' (OGEN) quarterly Tax Provisions came in at -$22625.0 in Q1 2026, up 94.75% on a QoQ basis from -$430770.0 in Q4 2018.
Oragenics (OGEN) Tax Provisions (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 10 years of Tax Provisions data on file, last reported at -$22625.0 in Q1 2026.
- Quarterly Tax Provisions changed N/A year-over-year to -$22625.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$453395.0 (changed N/A YoY) and the FY2025 annual result came in at -$136910.0, down 12546.36% from the prior year.
- Tax Provisions advanced to -$22625.0 in Q1 2026, from -$430770.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of -$22625.0 in Q1 2026 to a low of -$22625.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Oragenics | 2.35 Mn | 2.35 Mn | - | -46,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46,377.00 |
| Mar 31, 2026 | -22,625.00 |
| Dec 31, 2018 | -430,770.00 |
| Mar 31, 2017 | 1,200.00 |
| Dec 31, 2016 | -254,584.00 |
| Sep 30, 2016 | -2,378.00 |
| Jun 30, 2016 | 1,200.00 |
| Dec 31, 2015 | 3.98 Mn |
| Sep 30, 2015 | 900.00 |
| Jun 30, 2015 | 900.00 |
| Mar 31, 2015 | 2,000.00 |
| Dec 31, 2014 | -5,740.00 |
| Sep 30, 2014 | 2,046.00 |
| Jun 30, 2014 | 1,500.00 |
| Dec 31, 2013 | 211.00 |
| Sep 30, 2013 | 2,024.00 |
| Jun 30, 2013 | 3,000.00 |
| Mar 31, 2013 | 3,800.00 |
| Dec 31, 2012 | 44,823.00 |
| Sep 30, 2012 | 8,776.00 |